The Relative Strength (RS) Rating for Veeva Systems Cl A moved into a new percentile Friday, as it got a lift from 66 to 74.
IBD's proprietary rating tracks price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the trailing 52 weeks holds up against all the other stocks in our database.
History shows that the market's biggest winners typically have an RS Rating north of 80 in the early stages of their moves. See if Veeva Systems Cl A can continue to show renewed price strength and hit that benchmark.
How To Invest In Stocks In Both Bull And Bear Markets
Veeva Systems Cl A is not currently showing a potential entry point. See if the stock goes on to build a chart pattern that could launch a new move.
Veeva Systems Cl A posted 31% earnings growth in the latest quarterly report. Revenue rose 13%.
The company earns the No. 3 rank among its peers in the Computer Software-Medical industry group. Doximity is the top-ranked stock within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
